Parameters | All (n = 110) |
---|---|
Mean decrease Hb level at day 3, g/dL [SD] | -2.17 [1.42] |
Adverse drug events (%) | |
Anemia, Hb < 10.5 g/dL (%) WHO grade 1 (9.5 < Hb < 10.5) WHO grade 2 (8 < Hb < 9.5) WHO grade 3 (6.5 < Hb < 8) Hepatic disorders (transaminases elevation) (%) Abnormal kalemia, < 3.4 or > 4.5 mmol/L (%) Creatinine level > 265 µmol/L (%) Abnormal platelet count, < 150 or > 400 G/L (%) | 44 (40.4) 19 (43.2) 17 (38.6) 8 (18.2) 21 (19.3) 14 (12.8) 2 (1.8) 0 (0) |